PAP
IMCR icon

Persistent Asset Partners’s Immunocore IMCR Stock Holding History

Persistent Asset Partners’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
65,214
+16,252
+33% +$481K 0.62% 36
2026
Q1 		$1.48M Buy
48,962
+21,030
+75% +$680K 0.55% 46
2025
Q4 		$970K Sell
27,932
-683
-2% -$24.1K 0.44% 64
2025
Q3 		$1.04M Buy
28,615
+4,577
+19% +$156K 0.71% 43
2025
Q2 		$754K Buy
24,038
+1,708
+8% +$53.1K 0.56% 55
2025
Q1 		$663K Buy
+22,330
New +$670K 0.56% 52

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Persistent Asset Partners's IMCR Position: Q2 2026 in Review

Persistent Asset Partners increased its Immunocore (IMCR) stake by 33% in Q2 2026, buying an estimated $481K and bringing the position to 65,214 shares worth $2.07M. The position accounts for 0.62% of the portfolio, ranked #36.

Persistent Asset Partners first reported a position in IMCR in Q1 2025 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Persistent Asset Partners held 65,214 shares of Immunocore worth $2.07M as of Q2 2026.
  • Persistent Asset Partners bought 16,252 Immunocore shares in Q2 2026, an estimated $481K.
  • Immunocore made up 0.62% of Persistent Asset Partners's portfolio in Q2 2026, its #36 holding.
  • Persistent Asset Partners first reported a position in Immunocore in Q1 2025 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.